BioSpace News Archive

The Company announces internal investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses

Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Wednesday, November 13, 2019, it will release third quarter 2019 financial results and host a conference call at 5:00 p.m. Eastern Standard Time / 2:00 p.m. Pacific Standard Time to discuss the financial results and recent business developments.

Endo International plc (NASDAQ: ENDP) today announced that it will present data on the use of a standing MRI as compared to prone MRI for the evaluation of cellulite at the upcoming Annual Meeting of the American Society for Dermatologic Surgery (ASDS) in Chicago, IL.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, plans to report third quarter 2019 financial results on Thursday, November 7, 2019, after the close of U.S. markets.

Strong financials paving the way for broadening the business

Achieve Life Sciences, Inc. announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.

Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, provides an update to its shareholders.

Management will be accompanied by Sergio Giralt, M.D., Chief Attending Physician, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center to present data from 50 percent enrollment in the Phase 3 trial

ADVANZ PHARMA Corp. announced it intends to release its third quarter, 2019 financial results before market open on Thursday, November 7, 2019..

Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual American Society for Dermatologic Surgery Annual Meeting in Chicago, IL from October 24th-27th, 2019 at booth #401.